Toggle navigation
Publications
Researchers
Institutions
0
Sign In
Federated Authentication
(Click on the image)
Local Sign In
Password Recovery
Register
Sign In
David Scott Miller
AuthID:
R-00K-250
Publications
Confirmed
To Validate
Document Source:
All
Document Type:
All Document Types
Article (256)
Proceedings Paper (14)
Review (13)
Book Chapter (7)
Letter (4)
Note (4)
Editorial Material (3)
Unpublished (2)
Correction (1)
Year Start - End:
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
-
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
Order:
Year Dsc
Year Asc
Cit. WOS Dsc
IF WOS Dsc
Cit. Scopus Dsc
IF Scopus Dsc
Title Asc
Title Dsc
Results:
10
20
30
40
50
Confirmed Publications: 304
1
TITLE:
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Full Text
AUTHORS:
Clements, A; Enserro, D; Strickland, KC; Previs, R; Matei, D; Mutch, D; Powell, M; Klopp, A;
David Scott Miller
; Small, W Jr; Disilvestro, P; Spirtos, N; Cosgrove, C; Sfakianos, G; Liu, JR; Vargas, R; Shahin, M; Corr, B; Dessources, K; Ueland, F;
Warshal, D;
Gillen, J;
Secord, AA;
...More
PUBLISHED:
2025
,
SOURCE:
GYNECOLOGIC ONCOLOGY,
VOLUME:
193
INDEXED IN:
Scopus
WOS
CrossRef
Unpaywall
IN MY:
ORCID
2
TITLE:
Surgical staging identifies occult metastases in over 50% of uterine-confined carcinosarcoma
AUTHORS:
William Vintzileos; Hannah Beer;
David Scott Miller
; Jayanthi Lea;
PUBLISHED:
2025
,
SOURCE:
Gynecologic Oncology Reports,
VOLUME:
58
INDEXED IN:
CrossRef
Unpaywall
3
TITLE:
187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
AUTHORS:
Jalid Sehouli; Ignace Vergote; Erika Hamilton; Alejandro Pérez Fidalgo; Toon Van Gorp; Giovanni Scambia; Jaroslav Klat; Tally Levy; Stephen Welch; Debra L Richardson; Eva Maria Guerra Alía; Stéphanie Henry; Pauline Wimberger;
David Scott Miller
; Jerónimo Martínez; Bradley J Monk; Pratheek Kalyanapu; Monsoor Raza Mirza; Vicky Makker;
PUBLISHED:
2024
,
SOURCE:
Oral Sessions
INDEXED IN:
CrossRef
:
2
IN MY:
ORCID
|
CIÊNCIAVITAE
4
TITLE:
Dose-expansion part of a phase 1b global study of E7386 in combination with lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC) and other solid tumors including endometrial cancer (EC).
AUTHORS:
Jung-Yun Lee; Baek-Yeol Ryoo; Jin Won Kim; Ann-Lii Cheng; Richard S Finn; Kosei Hasegawa; Vicky Makker; Masatoshi Kudo;
David Scott Miller
; Philippe Merle; Susanna Varkey Ulahannan; Tetsuya Hosaka; Takatoshi Sahara; Cixin S He; Karen O'Hara; Lea Dutta; Toshiyuki Tamai; Masafumi Ikeda;
PUBLISHED:
2024
,
SOURCE:
Journal of Clinical Oncology,
VOLUME:
42,
ISSUE:
16_suppl
INDEXED IN:
CrossRef
IN MY:
ORCID
|
CIÊNCIAVITAE
5
TITLE:
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
AUTHORS:
Daniela E Matei; Danielle M Enserro; Marcus E Randall; David Mutch; William Small; Paul A DiSilvestro; Nick M Spirtos; David M O’Malley; Guilherme H Cantuaria; David Michelin; Steven Waggoner; Mark Shahin; Saketh Guntupalli; Olivia Lara; Frederick R Ueland; David Warshal; Albert Bonebrake; Krishnansu S Tewari; Annie Tan; Matthew A Powell;
Joan L Walker;
Alessandro D Santin;
Jong Hyeok Kim;
David Scott Miller
;
...More
PUBLISHED:
2024
,
SOURCE:
Journal of Clinical Oncology
INDEXED IN:
CrossRef
IN MY:
ORCID
|
CIÊNCIAVITAE
6
TITLE:
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Full Text
AUTHORS:
Vicky Makker; Jose Alejandro Perez Fidalgo; Giorgio Valabrega; Erika Hamilton; Toon Van Gorp; Jalid Sehouli; Klaudia Regináčová; Debra L Richardson; Tamar Perri; Amit M Oza;
David Scott Miller
; Eva Maria Guerra Alía; Ugo De Giorgi; Stephanie Henry; Daniel L Spitz; Pauline Wimberger; Markéta Bednaříková; Hye Sook Chon; Jerónimo Martínez Garcia; Carmela Pisano;
Jonathan S Berek;
Ignacio Romero;
Giovanni Scambia;
Lorena Fariñas Madrid;
Joseph Buscema;
Fabienne Schochter;
Kai Li;
Pratheek Kalyanapu;
Christopher J Walker;
Ignace Vergote;
...More
PUBLISHED:
2024
,
SOURCE:
Gynecologic Oncology,
VOLUME:
185
INDEXED IN:
Scopus
CrossRef
:
3
IN MY:
ORCID
|
CIÊNCIAVITAE
7
TITLE:
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. Featured Updates to the NCCN Guidelines
AUTHORS:
Joyce Liu; Andrew Berchuck; Floor J Backes; Joshua Cohen; Rachel Grisham; Charles A Leath; Lainie Martin; Daniela Matei;
David Scott Miller
; Sharon Robertson; Lisa Barroilhet; Shitanshu Uppal; Andrea Wahner Hendrickson; David M Gershenson; Heidi J Gray; Ardeshir Hakam; Angela Jain; Gottfried E Konecny; John Moroney; Elena Ratner;
John Schorge;
Premal H Thaker;
Theresa L Werner;
Emese Zsiros;
Kian Behbakht;
Lee-May Chen;
Marie DeRosa;
Eric L Eisenhauer;
Gary Leiserowitz;
Babak Litkouhi;
Michael McHale;
Sanja Percac-Lima;
Kerry Rodabaugh;
Roberto Vargas;
Frankie Jones;
Emily Kovach;
Lisa Hang;
Swathi Ramakrishnan;
Ronald D Alvarez;
Deborah K Armstrong;
...More
PUBLISHED:
2024
,
SOURCE:
Journal of the National Comprehensive Cancer Network,
VOLUME:
22,
ISSUE:
8
INDEXED IN:
CrossRef
IN MY:
ORCID
|
CIÊNCIAVITAE
8
TITLE:
Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis.
AUTHORS:
Vicky Makker; Debra L Richardson; Hye Sook Chon;
David Scott Miller
; Morten Mau-Sørensen; David Cibula; Flora Zagouri; Alejandro Pérez Fidalgo; Brian M Slomovitz; Robert L Coleman; Pratheek Kalyanapu; Rong Fan; Girish Gudi; Ignace Vergote;
PUBLISHED:
2024
,
SOURCE:
Journal of Clinical Oncology,
VOLUME:
42,
ISSUE:
16_suppl
INDEXED IN:
CrossRef
IN MY:
ORCID
|
CIÊNCIAVITAE
9
TITLE:
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279
AUTHORS:
Neil S Horowitz; Wei Deng; Ivy Peterson; Robert S Mannel; Spencer Thompson; Elizabeth Lokich; Tashanna Myers; Parvis Hanjani; David M O'Malley; Ki Young Chung;
David Scott Miller
; Frederick R Ueland; Don S Dizon; Austin Miller; Jyoti S Mayadev; Charles A Leath; Bradley J Monk;
PUBLISHED:
2024
,
SOURCE:
Journal of Clinical Oncology,
VOLUME:
42,
ISSUE:
16
INDEXED IN:
Scopus
CrossRef
Unpaywall
IN MY:
ORCID
10
TITLE:
Predicting Vte and Utility of Thromboprophylaxis in Metastatic and Recurrent Cervical Cancer
AUTHORS:
Christopher A Walker; Carson Edwards; Don McIntire; Lydia Makepeace; Steven B Holloway; Ev Kakadiaris; Alexandra Spirtos;
David Scott Miller
; Jayanthi Lea;
PUBLISHED:
2024
INDEXED IN:
CrossRef
IN MY:
ORCID
|
CIÊNCIAVITAE
Add to Marked List
Check All
Export
×
Publication Export Settings
BibTex
EndNote
APA
CSV
PDF
Export Preview
Print
×
Publication Print Settings
HTML
PDF
Print Preview
Page 1 of 31. Total results: 304.
<<
<
1
2
3
4
5
6
7
8
9
>
>>
×
Select Source
This publication has:
2 records from
ISI
2 records from
SCOPUS
2 records from
DBLP
2 records from
Unpaywall
2 records from
Openlibrary
2 records from
Handle
2 records from
DataCite
Please select which records must be used by Authenticus!
×
Preview Publications
© 2025 CRACS & Inesc TEC - All Rights Reserved
Privacy Policy
|
Terms of Service